Video

Dr. Newman on Health Disparities in Breast Cancer

Lisa Newman, MD, MPH, FACS, FASCO, chief of Breast Surgery, Weill Cornell Medical Center and NewYork-Presbyterian, discusses health disparities among women with breast cancer.

Lisa Newman, MD, MPH, FACS, FASCO, chief of Breast Surgery, Weill Cornell Medical Center and NewYork-Presbyterian, discusses health disparities among women with breast cancer.

Much of the research regarding health disparities has been done in African-American and Caucasian patients as that is where the biggest differential is, says Newman. Specifically, in breast cancer, higher disease-specific mortality is seen in African Americans than in Caucasians. Additionally, a higher proportion of breast cancer cases are diagnosed in younger women in the African-American community than in the Caucasian community, she adds. More concerningly is the higher degree to which biologically aggressive cancers manifest in African Americans than in Caucasians. Triple-negative breast cancers are twice as common among African-American women than in Caucasian women.

There are several reasons for these disparities, explains Newman. For example, socioeconomic disadvantages among the African-American community, which hinder their ability to access adequate healthcare coverage. This in turn can delay the time to diagnosis, which may explain why these patients present with more advanced-stage disease. The patterns regarding younger age and more aggressive disease among these patients are more likely related to tumor biology and genetics, says Newman.

Related Videos
Jacob Sands, MD, oncology medical director, International Patient Center, Dana-Farber Cancer Institute; assistant professor, Harvard Medical School
Fred R. Hirsch, MD, PhD, executive director, Center for Thoracic Oncology, The Tisch Cancer Institute at Mount Sinai; Joe Lowe and Louis Price Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai
Lori Wirth, MD
Tanios Bekaii-Saab, MD, FACP
Moritz Fürstenau, MD
Jun Gong, MD
Thierry Facon, MD
Alicia Morgans, MD, MPH, genitourinary medical oncologist, medical director, Survivorship Program, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Marshall Posner, MD
Renee Saliby, MD, MSc